BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21088392)

  • 21. The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis.
    Agle SC; McNally MM; Powell CS; Bogey WM; Parker FM; Stoner MC
    Ann Vasc Surg; 2010 Jul; 24(5):609-14. PubMed ID: 20413257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of intravenous thrombolysis in stroke patients weighing over 100 kg.
    Sarikaya H; Arnold M; Engelter ST; Lyrer PA; Mattle HP; Michel P; Odier C; Weder B; Siebel P; Mueller F; Ballinari P; Georgiadis D; Baumgartner RW
    Cerebrovasc Dis; 2011; 32(3):201-6. PubMed ID: 21822011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry.
    Miyagi T; Koga M; Shiokawa Y; Nakagawara J; Hasegawa Y; Furui E; Kimura K; Kario K; Okuda S; Yamagami H; Okada Y; Nezu T; Maeda K; Endo K; Minematsu K; Toyoda K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1098-106. PubMed ID: 23063059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
    Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
    Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated-measures analysis of the National Institute of Neurological Disorders and Stroke rt-PA stroke trial.
    Feng W; Vasquez G; Suri MF; Lakshminarayan K; Qureshi AI
    J Stroke Cerebrovasc Dis; 2011; 20(3):241-6. PubMed ID: 20621509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protocol adherence and safety of intravenous thrombolysis after telephone consultation with a stroke center.
    Uchino K; Massaro L; Jovin TG; Hammer MD; Wechsler LR
    J Stroke Cerebrovasc Dis; 2010; 19(6):417-23. PubMed ID: 21051004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
    Sobesky J; Frackowiak M; Zaro Weber O; Hahn M; Möller-Hartmann W; Rudolf J; Neveling M; Grond M; Schmulling S; Jacobs A; Heiss WD
    Cerebrovasc Dis; 2007; 24(1):56-65. PubMed ID: 17519545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fixed Dose IV rt-PA and Clinical Outcome in Ischemic Stroke Patients With Body Weight >100 kg: Pooled Data From 3 Randomized Clinical Trials.
    Majidi S; Leon Guerrero CR; Burger KM; Sigounas D; Olan WJ; Qureshi AI
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2843-2848. PubMed ID: 30076113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A model to prevent fibrinolysis in patients with stroke mimics.
    Chang J; Teleb M; Yang JP; Alderazi YJ; Chapple K; Frey JL; Restrepo L
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):839-43. PubMed ID: 21640609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of serum lipid levels on stroke outcome after rt-PA therapy: SAMURAI rt-PA registry.
    Makihara N; Okada Y; Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Hasegawa Y; Kario K; Okuda S; Naganuma M; Toyoda K
    Cerebrovasc Dis; 2012; 33(3):240-7. PubMed ID: 22261711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study.
    Momosaki R; Yasunaga H; Kakuda W; Matsui H; Fushimi K; Abo M
    Cerebrovasc Dis; 2016; 42(1-2):41-8. PubMed ID: 26986718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics and outcome of ischemic stroke patients who are free of symptoms at 24 hours following thrombolysis.
    Strbian D; Sairanen T; Rantanen K; Piironen K; Atula S; Tatlisumak T; Soinne L;
    Cerebrovasc Dis; 2011; 31(1):37-42. PubMed ID: 20980752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracerebral hemorrhage after thrombolytic therapy in acute ischemic stroke patients with renal dysfunction.
    Chao TH; Lin TC; Shieh Y; Chang TY; Hung KL; Liu CH; Lee TH; Chang YJ; Lee JD; Chang CH
    Eur Neurol; 2013; 70(5-6):316-21. PubMed ID: 24080988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.
    Bravo Y; Martí-Fàbregas J; Cocho D; Rodríguez-Yáñez M; Castellanos M; de la Ossa NP; Roquer J; Obach V; Maestre J; Martí-Vilalta JL
    Cerebrovasc Dis; 2008; 26(2):126-33. PubMed ID: 18560215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
    Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Favourable renal outcomes after intravenous thrombolytic therapy for acute ischemic stroke: Clinical implication of kidney-brain axis.
    Chang TH; Chiu PF; Tsai CC; Chang CH; Wu CL; Kor CT; Li JR; Kuo CL; Huang CS; Chu CC; Lin CM; Chang CC
    Nephrology (Carlton); 2019 Sep; 24(9):896-903. PubMed ID: 30334303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early stroke treatment with IV t-PA associated with early recanalization.
    Kimura K; Iguchi Y; Shibazaki K; Aoki J; Watanabe M; Matsumoto N; Yamashita S
    J Neurol Sci; 2010 Aug; 295(1-2):53-7. PubMed ID: 20570289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does dementia increase risk of thrombolysis?: a case-control study.
    Alshekhlee A; Li CC; Chuang SY; Vora N; Edgell RC; Kitchener JM; Kale SP; Feen E; Piriyawat P; Callison RC; Cruz-Flores S
    Neurology; 2011 May; 76(18):1575-80. PubMed ID: 21451151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.